3/19/2025 | CAHYLM | Bausch Health to redeem notes via proceeds of new notes, term loan
|
9/28/2022 | CADDHYLM | Bausch Health gives final results of exchange offer, consent bid
|
9/14/2022 | CADDHYLM | Bausch Health gives early results of exchange offer, consent bid
|
9/8/2022 | CADDHYLM | Bausch Health clarifies provisions of exchange offer, consent bid
|
8/31/2022 | CADDHYLM | Bausch Health launches $4 billion exchange offer, consent solicitation
|
8/9/2022 | BKBWCAHYLM | Bausch buys $481 million bonds at a discount; no debt due until 2025
|
5/10/2022 | CAHYLM | Bausch Health cancels redemption of 9% senior notes due 2025
|
4/25/2022 | CAHYLM | Bausch Health sets redemption price for 6 1/8% senior notes
|
4/18/2022 | CAHYLM | Bausch Health again delays redemption of 6 1/8%, 9% senior notes
|
3/14/2022 | CAHYLM | Bausch Health pushes back redemption of 6 1/8%, 9% senior notes
|
2/24/2022 | BKBWCAHYLM | Bausch Health de-levers to 6.5x, will de-lever subsidiaries as well
|
1/18/2022 | CAHYLM | Bausch Health intends to issue conditional notices of redemption
|
8/3/2021 | CAHYLM | Bausch Health will redeem additional $350 million 6 1/8% notes
|
7/1/2021 | CAHYLM | Bausch Health eyes partial redemption of 6 1/8% note due 2025
|
6/22/2021 | CAHYLM | Bausch Health extends tender offer for 7% secured notes due 2024 to reflect new federal holiday
|
6/7/2021 | CAHYLM | Bausch Health sees early tenders of $545.08 million 7% notes due 2024
|
5/27/2021 | CAHYLM | Bausch Health to redeem C$100 million 6 1/8% notes due 2025
|
5/24/2021 | CAHYLM | Bausch Health commences tender offer for 7% secured notes due 2024
|
5/3/2021 | CAHYLM | Bausch Health to redeem C$100 million more 7% secured notes on June 2
|
4/7/2021 | CAHYLM | Bausch Health to redeem C$100 million more 7% secured notes due 2024
|
2/26/2021 | CAHYLM | Bausch Health to redeem C$100 million 7% senior notes due 2024
|
2/22/2021 | CAHYLM | Bausch Health to redeem C$100 million of 7% senior notes due 2024
|
11/18/2020 | CAHYLM | Bausch Health eyes redemption of 4½%, 5½% notes due 2023
|
11/18/2020 | CAHYLM | Bausch Health to redeem all €1.5 billion 4.5% senior notes due 2023
|
10/29/2020 | CAHYLM | Bausch Health to redeem 5 7/8% notes, C$50 million of 5½% notes
|
8/31/2020 | CAHYLM | Bausch Health to redeem C$100 million 5 7/8% senior notes due 2023
|
5/11/2020 | CAHYLM | Bausch Health conditionally calls $1.25 billion 6½% notes due 2022
|
3/2/2020 | BKCAHYLM | Bausch cancels plans for new notes, loan refinancing, redemption
|
2/19/2020 | CAHYLM | Bausch Health will redeem 6½% notes due 2022, 7% notes due 2024
|
2/12/2020 | CAHYLM | Bausch Health to redeem C$100 million 5½% notes due 2023
|
12/18/2019 | CAHYLM | Bausch Health calls $1.24 billion 5 7/8% notes due 2023
|
9/3/2019 | CAHYLM | Bausch Health to reduce debt by $200 million via paydown, redemption
|
5/23/2019 | CAHYLM | Bausch Health tender offer for 5½% notes, 5 7/8% notes oversubscribed
|
5/9/2019 | CAHYLM | Bausch launches tender offer for up to $1.5 billion of 2023 notes
|
3/8/2019 | CAHYLM | Bausch Health calls 2021 notes, announces early tender results
|
3/8/2019 | CAHYLM | Bausch Health announces early results of tender offers for notes
|
2/25/2019 | CAHYLM | Bausch Health ups tender offer price to $1.5 billion for three notes
|
2/22/2019 | CAHYLM | Bausch Health holds $1.25 billion tender offer for three note series
|
11/30/2018 | CAHYLM | Bausch Health to call $200 million 5 5/8% notes due 2021 on Dec. 31
|
11/27/2018 | CAHYLM | Bausch Health to redeem remaining 7½% notes due 2021 on Dec. 27
|
11/21/2018 | CAHYLM | Bausch Health sees $1.48 billion early tenders of 7½% notes due 2021
|
11/7/2018 | CAHYLM | Bausch Health tenders, solicits consents for 7½% notes due 2021
|
9/26/2018 | CAHYLM | Bausch Health calls $125 million 7½% notes due 2021
|
5/8/2018 | BKBWCAHYLM | Valeant cuts debt by $6.9 billion since 2016; ‘more work to be done’
|